Clinical Pharmacology

Regulatory, operations, ethical and quality requirementsin today’s early phase clinical trials (Course Modul 3) The German Association of Human Pharmacology (AGAH e.V.), the Association Francaise de Pharmacologie Translationelle (AFPT) in cooperation with the European Federation for Exploratory Medicines Development (EUFEMED) and its further Member Societies are developing a modular training course in Human Pharmacology, leading to qualifications at the certificate and diploma levels. The training courses are intended for physicians, biopharmaceutical scientists and healthcare professionals working in early phase clinical research and would also suit investigators intending to fulfil the role of Principal Investigator for First in Human (FIH) trials. Registration deadline: 25/10/2024 Minimum: 10 participants If there are fewer than 10 participants, the course cannot be organised.

conducted by Healixia, Belgium: Pharmacokinetics, pharmacodynamics and biomarkers in early clinical development This course addresses postgraduates in life sciences interested in early clinical development of medicinal products. The training provides an overview on pharmacokinetics (PK), pharmacodynamics (PD) and biomarkers in early clinical drug development spanning from non-clinical pharmacology over first-in-man studies to proof-of-concept clinical trials. Part 1: 15-17 January 2025, pharmacokinetics; 3 days at KU Leuven, Belgium Part 2: 2-3 April 2025, pharmacodynamics; 2 days at UGhent, Belgium Further details to follow.